Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Food and Drug Administration
- Recipient company
- EXCELLIMS CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NC3UP8JYE7E6
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): An electrospray ionization ion mobility spectrometer (ESI-IMS) is proposed to be used as an innovative process analytical technology (PAT) to overcome the limitations of current cleaning validation systems for pharmaceu
tical manufacturing and quality assurance. With its sensitivity, speed and portability, IMS has already been used in trace chemical detection that includes cleaning validation applications in pharmaceutical manufacturing processes. However, current commerc
ially available IMS systems have significant limitations in quantitative measurements and in the ability to analyze non-volatile organic and biological samples. In this project, an IMS is proposed to be interfaced to a novel electrospray ionization source
for on-site analysis of both small molecule and biological pharmaceuticals. The new system will accept samples either directly from a swab or extracted sample solution. As these samples are introduced into the IMS, the targeted analytes are ionized, separa
ted, and quantitatively detected within seconds. More importantly, the new IMS system allows detection of low charge affinity compounds and provides quantitative information of targeted active ingredients and other substance of interests. This on-site anal
ytical technology can significantly reduce manufacturing down time and associated costs in the pharmaceutical manufacturing industry. PUBLIC HEALTH RELEVANCE: The proposed electrospray ionization ion mobility spectrometry (ESI-IMS) based cleaning va
lidation technology is consistent with FDA's Process Analytical Technology (PAT) initiative, the goal of which is to improve efficiency in pharmaceutical manufacturing and quality assurance. This on-site analytical technology can significantly reduce manuf
acturing down time and associated costs in pharmaceutical manufacturing industry, and could help lead to lower pharmaceutical costs to the public. Compared to existing IMS based cleaning validation methods, the proposed innovative IMS device fundamentally
improves ion mobility spectrometry performance and enables direct introduction of swabbed samples, superior quantitative measurements, and the analysis of non-volatile and biological samples.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
11 SBIR/STTR records share this UEI (2006–2013). Reported award amounts total $2,431,566. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Environmental Protection Agency, National Science Foundation, Department of Homeland Security
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards